Enable Biosciences
About:
Enable Biosciences is a biotech company.
Website: https://www.enablebiosciences.com
Twitter/X: EnableBio
Top Investors: National Science Foundation, National Institutes of Health
Description:
Enable Biosciences is a biotech company making ultrasensitive tests for hiv, type 1 diabetes, and many other diseases. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.
Total Funding Amount:
$4.16M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
South San Francisco, California, United States
Founded Date:
2015-01-01
Contact Email:
info(AT)enablebiosciences.com
Founders:
Carolyn Bertozzi, DAVID SEFTEL, Jason Tsai
Number of Employees:
11-50
Last Funding Date:
2024-04-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai